New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export NVO’s income statement to Excel — free account
Novo Nordisk A/S
NVOHealthcare Drug Manufacturers General
Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024.
- Revenue
- +3.87%
- EPS
- −17.1%
- Free cash flow
- −14.8%
- Total debt
- +30.7%
Quarter to September 2026, against a year earlier
38.51
0.38
−0.98%
Follow NVO
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow of $8.9B covered $8.0B of dividends and buybacks. Cash rose by $1.6B. Lines the picture does not name came to −$4.6B. What is a cash flow statement?
- Free cash flow
- $8.9B 49.5% of operating cash flow
- Returned to shareholders
- $8.0B 90.1% of free cash flow
- Debt, net
- $3.7B borrowed
- Change in cash
- +$1.6B over the period
| Operating cash flow | 18.0 |
|---|---|
| Capital expenditures | −9.1 |
| Free cash flow | 8.9 |
| Acquisitions, net | +0.2 |
| From investments, net | +1.5 |
| Dividends | −7.8 |
| Buybacks, net | −0.2 |
| Debt raised, net | +3.7 |
| Other | −4.6 |
| Change in cash | 1.6 |
Free cash flow
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.2B | $6.3B | $6.8B | $7.0B | $8.0B | $8.8B | $11.2B | $15.8B | $17.5B | $18.0B |
| Capex | −$1.0B | −$1.2B | −$1.5B | −$1.3B | −$891M | −$1.0B | −$1.7B | −$3.7B | −$6.8B | −$9.1B |
| Free cash flow | $6.1B | $5.1B | $5.4B | $5.7B | $7.1B | $7.7B | $9.5B | $12.1B | $10.7B | $8.9B |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
15,508.51 | 14,643.26 | 12,150.77 | 7,862.34 | 7,598.14 | 6,455.54 | 5,838.76 | 5,906.22 | 5,791.95 | 5,635.66 |
Depreciation & Amortization |
3,328.08 | 2,770.52 | 1,366.77 | 1,042.46 | 958.58 | 881.36 | 848.58 | 600.13 | 483.35 | 474.48 |
Non Cash Items (Other) |
3,961.68 | 2,747.03 | 3,068.08 | 5,075.94 | 3,871.22 | 2,886.44 | 1,621.32 | 1,477.93 | 1,527.96 | 1,439.64 |
Accounts Receivable Change |
165.48 | (1,040.95) | (2,063.29) | (1,404.25) | (2,053.82) | (432.33) | (318.69) | (400.75) | 10.48 | (705.70) |
Change in inventories |
(1,328.38) | (1,310.51) | (1,077.82) | (675.01) | (172.62) | (137.11) | (195.62) | (147.24) | (156.76) | (235.23) |
Accounts Payable Change |
396.37 | 469.80 | 1,454.76 | 951.13 | 501.64 | (98.20) | (59.66) | 175.22 | (60.91) | 161.08 |
Change in other assets and liabilities |
1,153.21 | 3,374.01 | 4,590.06 | 372.55 | 347.63 | 0.77 | 938.22 | 686.06 | 37.67 | 833.20 |
Other operating activities |
(5,152.90) | (4,112.78) | (3,675.88) | (2,054.76) | (2,300.27) | (1,597.57) | (1,660.29) | (1,475.79) | (1,380.31) | (423.66) |
Operating Cash Flow |
18,032.04 | 17,540.36 | 15,813.44 | 11,170.40 | 8,750.50 | 7,958.89 | 7,012.62 | 6,821.79 | 6,253.42 | 7,179.46 |
Capital expenditures |
(9,105.20) | (6,838.78) | (3,747.03) | (1,719.87) | (1,007.90) | (891.32) | (1,338.31) | (1,471.36) | (1,157.02) | (1,049.26) |
Change in intangibles (net) |
(4,537.91) | (601.02) | (1,900.67) | (369.15) | (167.05) | (2,490.42) | (344.62) | (424.14) | (155.24) | (178.17) |
Net Aquisitions |
152.01 | (11,913.63) | — | (1,001.82) | (2,908.82) | — | (0.45) | 56.27 | — | — |
Short Term Investments Change (Net) |
1,536.10 | 777.64 | (690.86) | (413.61) | 186.47 | — | — | — | 305.17 | 306.71 |
Long-Term Investments Change (Net) |
(29.52) | (113.97) | (34.56) | (23.93) | (1,131.68) | (58.22) | (44.82) | (10.70) | 5.01 | (92.13) |
Other investing activities |
— | — | — | — | 0.64 | 2.76 | 3.00 | 2.91 | 3.95 | 3.86 |
Investing cash flow |
(11,984.52) | (18,689.78) | (6,373.12) | (3,528.39) | (5,028.35) | (3,437.19) | (1,725.20) | (1,847.03) | (998.13) | (1,008.99) |
Repayment/Issuance of Debt (Net) |
3,746.09 | 10,593.12 | (213.01) | (340.97) | 2,461.44 | 724.94 | (111.08) | 14.37 | — | — |
Equity Repurchase (Common, Net) |
(210.14) | (2,926.24) | (4,344.96) | (3,410.58) | (3,094.02) | (2,582.19) | (2,298.57) | (2,380.19) | (2,558.76) | (2,237.47) |
Dividends Paid (Total) |
(7,836.92) | (6,400.30) | (4,612.57) | (3,582.90) | (3,423.35) | (3,082.54) | (2,909.41) | (2,912.44) | (2,862.40) | (3,541.14) |
Financing cash flow |
(4,300.97) | 1,266.58 | (9,170.54) | (7,334.45) | (4,055.94) | (4,939.78) | (5,319.05) | (5,278.26) | (5,421.16) | (5,778.61) |
Exchange Rate Adjustment |
(110.07) | 65.98 | (17.28) | (33.70) | 94.03 | (69.86) | (1.05) | 6.73 | (32.05) | (3.86) |
Discontinued Operations and Adjustments |
— | — | — | — | — | — | — | 62.99 | — | — |
Change in Cash |
1,636.48 | 183.14 | 252.50 | 273.85 | (239.76) | (487.94) | (32.68) | (233.78) | (197.93) | 387.99 |
Beginning Cash |
2,370.17 | 2,086.84 | 1,837.22 | 1,517.81 | 1,945.16 | 2,360.97 | 2,342.79 | 2,623.46 | 2,804.23 | 2,355.31 |
Ending Cash |
4,006.65 | 2,269.98 | 2,089.72 | 1,791.67 | 1,705.39 | 1,873.02 | 2,310.11 | 2,389.67 | 2,606.30 | 2,743.31 |
Stock Based Compensation |
217.26 | 331.91 | 312.03 | — | — | — | 54.41 | 63.30 | — | 54.68 |
Dividends Paid (Common) |
(7,836.92) | (6,400.30) | (4,612.57) | (3,582.90) | (3,423.35) | (3,082.54) | (2,909.41) | (2,912.44) | (2,862.40) | (3,541.14) |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
386.68 | 1,492.34 | 2,903.71 | (755.58) | (1,377.17) | (666.88) | 364.26 | 313.29 | (169.52) | 53.35 |
Investments Change (Net) |
1,506.58 | 663.67 | (725.42) | (437.54) | (945.21) | (58.22) | (44.82) | (10.70) | 310.18 | 214.58 |
Issuance/Purchase of Shares |
(210.14) | (2,926.24) | (4,344.96) | (3,410.58) | (3,094.02) | (2,582.19) | (2,298.57) | (2,380.19) | (2,558.76) | (2,237.47) |
| Other line items | ||||||||||
Revenue per Employee |
0.67 | 0.54 | 0.53 | 0.45 | 0.50 | 0.43 | 0.42 | 0.40 | 0.40 | 0.40 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026